ChemoCentryx Announces Publication in The New England Journal of Medicine of Results of the Pivotal Phase III ADVOCATE Trial of Avacopan for the Treatment of ANCA-Associated Vasculitis

Ads

You May Also Like

John M. Dineen Appointed to Syneos Health Board of Directors, Named Chairman

MORRISVILLE, N.C., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq:SYNH), the only fully ...

HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2015 Results

TUCSON, Ariz., March 24, 2016 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), a ...

Genmab Announces Data to be Presented at 2017 ASCO Annual Meeting

Media Release 8 abstracts on Genmab programs scheduled for presentation at ASCO Two daratumumab ...